Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach

by Gasperini, Claudio, Ruggieri, Serena
Published 2012

Emerging oral treatments in multiple sclerosis – clinical utility of cladribine tablets

by Gasperini, Claudio, Ruggieri, Serena, Pozzilli, Carlo
Published 2010

Efficacy and safety of laquinimod in multiple sclerosis: current status

by Haggiag, Shalom, Ruggieri, Serena, Gasperini, Claudio
Published 2013

Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing–remitting multiple sclerosis

by Ruggieri, Serena, Tortorella, Carla, Gasperini, Claudio
Published 2014

Advances in the treatment of relapsing—remitting multiple sclerosis — critical appraisal of fingolimod

by Gasperini, Claudio, Ruggieri, Serena, Mancinelli, Chiara Rosa, Pozzilli, Carlo
Published 2013

Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis

by Corsetti, Marta, Ruocco, Gabriella, Ruggieri, Serena, Gasperini, Claudio, Battistini, Luca, Volpe, Elisabetta
Published in Int J Mol Sci (2019)

Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled Trial

by Prosperini, Luca, Castelli, Letizia, De Giglio, Laura, Bonanno, Valeria, Gasperini, Claudio, Pozzilli, Carlo
Published in Neurotherapeutics (2019)

Dalfampridine improves slowed processing speed in multiple sclerosis patients with mild motor disability: post hoc analysis of a randomized controlled trial

by Pozzilli, Carlo, Prosperini, Luca, Tommasin, Silvia, Gasperini, Claudio, Barbuti, Elena, De Giglio, Laura
Published in Ther Adv Neurol Disord (2021)

CD28 Autonomous Signaling Up-Regulates C-Myc Expression and Promotes Glycolysis Enabling Inflammatory T Cell Responses in Multiple Sclerosis

by Kunkl, Martina, Sambucci, Manolo, Ruggieri, Serena, Amormino, Carola, Tortorella, Carla, Gasperini, Claudio, Battistini, Luca, Tuosto, Loretta
Published in Cells (2019)

Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: a retrospective study

by Sbardella, Emilia, Tomassini, Valentina, Gasperini, Claudio, Bellomi, Francesca, Cefaro, Luca Ausili, Morra, Vincenzo Brescia, Antonelli, Guido, Pozzilli, Carlo
Published 2009

Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple Sclerosis

by Giorgio, Antonio, Battaglini, Marco, Gentile, Giordano, Stromillo, Maria Laura, Gasperini, Claudio, Visconti, Andrea, Paolillo, Andrea, De Stefano, Nicola
Published in Front Neurol (2020)

A Comprehensive Review on Copemyl(®)

by Annovazzi, Pietro, Bertolotto, Antonio, Brescia Morra, Vincenzo, Gasperini, Claudio, Montanari, Enrico, Navarra, Pierluigi, Patti, Francesco, Sormani, Maria Pia, Ghezzi, Angelo
Published in Neurol Ther (2017)

Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®)

by Annovazzi, Pietro, Bertolotto, Antonio, Brescia Morra, Vincenzo, Gasperini, Claudio, Montanari, Enrico, Navarra, Pierluigi, Patti, Francesco, Pia Sormani, Maria, Ghezzi, Angelo
Published in Neurol Ther (2018)

Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients

by Capone, Alessia, Bianco, Manuela, Ruocco, Gabriella, De Bardi, Marco, Battistini, Luca, Ruggieri, Serena, Gasperini, Claudio, Centonze, Diego, Sette, Claudio, Volpe, Elisabetta
Published in Cells (2019)

Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus

by Filippi, Massimo, Capra, Ruggero, Centonze, Diego, Gasperini, Claudio, Patti, Francesco, Perini, Paola, Pozzilli, Carlo, Rocca, Maria A., Uccelli, Antonio, Trojano, Maria
Published in J Neurol (2021)

Dynamics of pseudo‐atrophy in RRMS reveals predominant gray matter compartmentalization

by De Stefano, Nicola, Giorgio, Antonio, Gentile, Giordano, Stromillo, Maria Laura, Cortese, Rosa, Gasperini, Claudio, Visconti, Andrea, Sormani, Maria Pia, Battaglini, Marco
Published in Ann Clin Transl Neurol (2021)

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

by Hupperts, Raymond, Lycke, Jan, Short, Christine, Gasperini, Claudio, McNeill, Manjit, Medori, Rossella, Tofil-Kaluza, Agata, Hovenden, Maria, Mehta, Lahar R, Elkins, Jacob
Published in Mult Scler (2016)

Switch Strategy from Direct Aspiration First Pass Technique to Solumbra Improves Technical Outcome in Endovascularly Treated Stroke

by Pampana, Enrico, Fabiano, Sebastiano, De Rubeis, Gianluca, Bertaccini, Luca, Stasolla, Alessandro, Pingi, Alberto, Cozzolino, Valeria, Mangiardi, Marilena, Anticoli, Sabrina, Gasperini, Claudio, Cotroneo, Enrico
Published in Int J Environ Res Public Health (2021)

Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus

by Centonze, Diego, Rocca, Maria A., Gasperini, Claudio, Kappos, Ludwig, Hartung, Hans-Peter, Magyari, Melinda, Oreja-Guevara, Celia, Trojano, Maria, Wiendl, Heinz, Filippi, Massimo
Published in J Neurol (2021)

Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis

by Amadio, Susanna, Parisi, Chiara, Piras, Eleonora, Fabbrizio, Paola, Apolloni, Savina, Montilli, Cinzia, Luchetti, Sabina, Ruggieri, Serena, Gasperini, Claudio, Laghi-Pasini, Franco, Battistini, Luca, Volonté, Cinzia
Published in Front Immunol (2017)